Search Results - "ENWERE, Godwin"

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) by Henao-Restrepo, Ana Maria, Dr, Camacho, Anton, PhD, Longini, Ira M, Prof, Watson, Conall H, MFPH, Edmunds, W John, Prof, Egger, Matthias, Prof, Carroll, Miles W, PhD, Dean, Natalie E, PhD, Diatta, Ibrahima, MSc, Doumbia, Moussa, MD, Draguez, Bertrand, MD, Duraffour, Sophie, PhD, Enwere, Godwin, FWACP, Grais, Rebecca, PhD, Gunther, Stephan, MD, Gsell, Pierre-Stéphane, PhD, Hossmann, Stefanie, MSc, Watle, Sara Viksmoen, MD, Kondé, Mandy Kader, Prof, Kéïta, Sakoba, MD, Kone, Souleymane, MSc, Kuisma, Eewa, PhD, Levine, Myron M, Prof, Mandal, Sema, MD, Mauget, Thomas, MBA, Norheim, Gunnstein, PhD, Riveros, Ximena, MSc, Soumah, Aboubacar, MD, Trelle, Sven, MD, Vicari, Andrea S, PhD, Røttingen, John-Arne, Prof, Kieny, Marie-Paule, PhD

“…Summary Background rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of…”
Get full text

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial by Henao-Restrepo, Ana Maria, MD, Longini, Ira M, Prof, Egger, Matthias, Prof, Dean, Natalie E, PhD, Edmunds, W John, Prof, Camacho, Anton, PhD, Carroll, Miles W, PhD, Doumbia, Moussa, MD, Draguez, Bertrand, MD, Duraffour, Sophie, PhD, Enwere, Godwin, FWACP, Grais, Rebecca, PhD, Gunther, Stephan, MD, Hossmann, Stefanie, MSc, Kondé, Mandy Kader, Prof, Kone, Souleymane, MSc, Kuisma, Eeva, PhD, Levine, Myron M, Prof, Mandal, Sema, MD, Norheim, Gunnstein, PhD, Riveros, Ximena, BSc, Soumah, Aboubacar, MD, Trelle, Sven, MD, Vicari, Andrea S, PhD, Watson, Conall H, MFPH, Kéïta, Sakoba, MD, Kieny, Marie Paule, Dr, Røttingen, John-Arne, Prof

“…Summary Background A recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of Zaire Ebolavirus…”
Get full text

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report by Gsell, Pierre-Stéphane, Camacho, Anton, Kucharski, Adam J, Watson, Conall H, Bagayoko, Aminata, Nadlaou, Séverine Danmadji, Dean, Natalie E, Diallo, Abdourahamane, Diallo, Abdourahmane, Honora, Djidonou A, Doumbia, Moussa, Enwere, Godwin, Higgs, Elizabeth S, Mauget, Thomas, Mory, Diakite, Riveros, Ximena, Oumar, Fofana Thierno, Fallah, Mosoka, Toure, Alhassane, Vicari, Andrea S, Longini, Ira M, Edmunds, W J, Henao-Restrepo, Ana Maria, Kieny, Marie Paule, Kéïta, Sakoba

“…In March, 2016, a flare-up of Ebola virus disease was reported in Guinea, and in response ring vaccination with the unlicensed rVSV-ZEBOV vaccine was…”
Get full text

Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative by Borrow, Ray, Lee, Jin-Soo, Vázquez, Julio A, Enwere, Godwin, Taha, Muhamed-Kheir, Kamiya, Hajime, Kim, Hwang Min, Jo, Dae Sun

“…Highlights • MD remains a public health issue of concern in many Asia-Pacific countries. • In the Asia-Pacific region, incidence rates likely underestimate the…”
Get full text

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches) by Watson, Conall H, Gsell, Pierre-Stéphane, Hall, Yper, Camacho, Anton, Riveros, Ximena, Enwere, Godwin, Vicari, Andrea, Nadlaou, Séverine Danmadji, Toure, Alhassane, Sani, Ismaila M, Diallo, Abdourahamane, Kolie, Cece, Duraffour, Sophie, Ifono, Kékoura, Maomou, Andre, Dore, Kassie, Djidonou, Honora A, Bagayoko, Aminata, Damey, Philos P, Camara, Mabetty Nancy, Diallo, Fatoumata Battouly, Oumar, Fofana Thierno, Toure, Kalidou, Diaby, Mohamed Lamine, Sylla, Lansana, Conde, Doussou, Kaba, Ibrahima Lansana, Tipton, Tom, Eggo, Rosalind M, Marks, Michael, Roberts, Chrissy H, Strecker, Thomas, Günther, Stephan, Keita, Sakoba, Edmunds, W. John, Carroll, Miles W, Henao-Restrepo, Ana Maria

“…Abstract Background Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in…”
Get full text

Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study by Khatib, Ahmed M, MD, Ali, Mohammad, Dr, von Seidlein, Lorenz, PhD, Kim, Deok Ryun, MSc, Hashim, Ramadhan, MSc, Reyburn, Rita, MSc, Ley, Benedikt, MPH, Thriemer, Kamala, MD, Enwere, Godwin, FWACP, Hutubessy, Raymond, PhD, Aguado, Maria Teresa, PhD, Kieny, Marie-Paule, PhD, Lopez, Anna Lena, MD, Wierzba, Thomas F, PhD, Ali, Said Mohammed, MSc, Saleh, Abdul A, MD, Mukhopadhyay, Asish K, PhD, Clemens, John, Prof, Jiddawi, Mohamed Saleh, MD, Deen, Jacqueline, MD

“…Summary Background Zanzibar, in east Africa, has been severely and repeatedly affected by cholera since 1978. We assessed the effectiveness of oral cholera…”
Get full text

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali by Chowdhury, Panchali Roy, Meier, Christian, Laraway, Hewad, Tang, Yuxiao, Hodgson, Abraham, Sow, Samba O., Enwere, Godwin C., Plikaytis, Brian D., Kulkarni, Prasad S., Preziosi, Marie-Pierre, Niedrig, Matthias

“…Background. Yellow fever (YF) is still a major public health problem in endemic regions of Africa and South America. In Africa, one of the main control…”
Get full text

Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials by Idoko, Olubukola T., Diallo, Aldiouma, Sow, Samba O., Hodgson, Abraham, Akinsola, Adebayo, Diarra, Bou, Haidara, Fadima Cheick, Ansah, Patrick Odum, Kampmann, Beate, Bouma, Enricke, Preziosi, Marie-Pierre, Enwere, Godwin C.

“…Background. The Meningitis Vaccine Project (MVP) was established to address epidemic meningitis as a public health problem in sub-Saharan Africa and, to that…”
Get full text

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years by Diallo, Aldiouma, Sow, Samba O., Idoko, Olubukola T., Hirve, Siddhivinayak, Findlow, Helen, Preziosi, Marie-Pierre, Elie, Cheryl, Kulkarni, Prasad S., Parulekar, Varsha, Diarra, Bou, Haidara, Fadima Cheick, Diallo, Fatoumata, Tapia, Milagritos, Akinsola, Adebayo K., Adegbola, Richard A., Bavdekar, Ashish, Juvekar, Sanjay, Chaumont, Julie, Martellet, Lionel, Marchetti, Elisa, LaForce, Marc F., Plikaytis, Brian D., Enwere, Godwin C., Tang, Yuxiao, Borrow, Ray, Carlone, George, Viviani, Simonetta

“…Background. Mass vaccination campaigns of the population aged 1–29 years with 1 dose of group A meningococcal (MenA) conjugate vaccine (PsA-TT, MenAfriVac) in…”
Get full text

Evaluation of a rapid dipstick (Crystal VC) for the diagnosis of cholera in Zanzibar and a comparison with previous studies by Ley, Benedikt, Khatib, Ahmed M, Thriemer, Kamala, von Seidlein, Lorenz, Deen, Jacqueline, Mukhopadyay, Asish, Chang, Na-Yoon, Hashim, Ramadhan, Schmied, Wolfgang, Busch, Clara J-L, Reyburn, Rita, Wierzba, Thomas, Clemens, John D, Wilfing, Harald, Enwere, Godwin, Aguado, Theresa, Jiddawi, Mohammad S, Sack, David, Ali, Said M

“…The gold standard for the diagnosis of cholera is stool culture, but this requires laboratory facilities and takes at least 24 hours. A rapid diagnostic test…”
Get full text

A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection by Mackenzie, Grant, Ceesay, Serign J, Hill, Philip C, Walther, Michael, Bojang, Kalifa A, Satoguina, Judith, Enwere, Godwin, D'Alessandro, Umberto, Saha, Debasish, Ikumapayi, Usman N A, O'Dempsey, Tim, Mabey, David C W, Corrah, Tumani, Conway, David J, Adegbola, Richard A, Greenwood, Brian M

“…Malaria is a risk factor for invasive non-typhoidal Salmonella (NTS) infection in children. In the last 10 years, indices of malaria infection in The Gambia…”
Get full text

Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age by Tapia, Milagritos D., Findlow, Helen, Idoko, Olubukola T., Preziosi, Marie-Pierre, Kulkarni, Prasad S., Enwere, Godwin C., Elie, Cheryl, Parulekar, Varsha, Sow, Samba O., Haidara, Fadima Cheick, Diallo, Fatoumata, Doumbia, Moussa, Akinsola, Adebayo K., Adegbola, Richard A., Kampmann, Beate, Chaumont, Julie, Martellet, Lionel, Marchetti, Elisa, Viviani, Simonetta, Tang, Yuxiao, Plikaytis, Brian D., LaForce, F. Marc, Carlone, George, Borrow, Ray

“…Background. Following mass vaccination campaigns in the African meningitis belt with group A meningococcal conjugate vaccine, MenAfriVac (PsA-TT), disease due…”
Get full text

A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians by Tapia, Milagritos D., Sow, Samba O., Haidara, Fadima Cheick, Diallo, Fatoumata, Doumbia, Moussa, Enwere, Godwin C., Paranjape, Gandhali, Hervé, Jacques, Bouma, Enricke, Parulekar, Varsha, Martellet, Lionel, Chaumont, Julie, Plikaytis, Brian D., Tang, Yuxiao, Kulkarni, Prasad S., Hartmann, Katharina, Preziosi, Marie-Pierre

“…Background. A safe, affordable, and highly immunogenic meningococcal A conjugate vaccine (PsA-TT, MenAfriVac) was developed to control epidemic group A…”
Get full text

Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays by Price, Gregory A., Hollander, Aimee M., Plikaytis, Brian D., Mocca, Brian T., Carlone, George, Findlow, Helen, Borrow, Ray, Sow, Samba O., Diallo, Aldiouma, Idoko, Olubukola T., Enwere, Godwin C., Elie, Cheryl, Preziosi, Marie-Pierre, Kulkarni, Prasad S., Bash, Margaret C.

“…Background. PsA-TT (MenAfriVac) is a conjugated polysaccharide vaccine developed to eliminate group A meningococcal disease in Africa. Vaccination of African…”
Get full text

Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons by Enwere, Godwin C., Paranjape, Gandhali, Kulkarni, Prasad S., Ginde, Manisha, Hartmann, Katharina, Viviani, Simonetta, Chaumont, Julie, Martellet, Lionel, Makadi, Marie-Francoise, Ivinson, Karen, Marchetti, Elisa, Herve, Jacques, Kertson, Kim, LaForce, F. Marc, Preziosi, Marie-Pierre

“…Background. The determination of the safety profile of any vaccine is critical to its widespread use in any population. In addition, the application of…”
Get full text

Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine by Martellet, Lionel, Sow, Samba O., Diallo, Aldiouma, Hodgson, Abraham, Kampmann, Beate, Hirve, Siddhivinayak, Tapia, Milagritos, Haidara, Fadima Cheick, Ndiaye, Assane, Diarra, Bou, Ansah, Patrick Odum, Akinsola, Adebayo, Idoko, Olubukola T., Adegbola, Richard A., Bavdekar, Ashish, Juvekar, Sanjay, Viviani, Simonetta, Enwere, Godwin C., Marchetti, Elisa, Chaumont, Julie, Makadi, Marie-Francoise, Pallardy, Flore, Kulkarni, Prasad S., Preziosi, Marie-Pierre, LaForce, F. Marc

“…Background. The group A meningococcal vaccine (PsA-TT) clinical development plan included clinical trials in India and in the West African region between 2005…”
Get full text

A review of the quality of randomized clinical trials of adjunctive therapy for the treatment of cerebral malaria by Enwere, Godwin

“…Summary Background  Randomized controlled clinical trials (RCTs) of adjunctive treatment to reduce the high‐mortality associated with cerebral malaria (CM)…”
Get full text

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine by Akinsola, Adebayo K, Ota, Martin O C, Enwere, Godwin C, Okoko, Brown J, Zaman, Syed M A, Saaka, Mark, Nsekpong, Ekpedeme D, Odutola, Aderonke A, Greenwood, Brian M, Cutts, Felicity T, Adegbola, Richard A

“…A 9-valent pneumococcal conjugate vaccine (PCV-9), given in a 3-dose schedule, protected Gambian children against pneumococcal disease and reduced…”
Get full text

Zinc as an adjunct therapy in the management of severe pneumonia among Gambian children: randomized controlled trial by Howie, Stephen, Bottomley, Christian, Chimah, Osaretin, Ideh, Readon, Ebruke, Bernard, Okomo, Uduak, Onyeama, Charles, Donkor, Simon, Rodrigues, Onike, Tapgun, Mary, Janneh, Marie, Oluwalana, Claire, Kuti, Bankole, Enwere, Godwin, Esangbedo, Pamela, Doherty, Conor, Mackenzie, Grant, Greenwood, Brian, Corrah, Tumani, Prentice, Andrew, Adegbola, Richard, Zaman, Syed

“…The benefit of zinc as an adjunct therapy for severe pneumonia is not established. We assessed the benefit of adjunct zinc therapy for severe pneumonia in…”
Get full text

Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy by Hashim, Ramadhan, Khatib, Ahmed M, Enwere, Godwin, Park, Jin Kyung, Reyburn, Rita, Ali, Mohammad, Chang, Na Yoon, Kim, Deok Ryun, Ley, Benedikt, Thriemer, Kamala, Lopez, Anna Lena, Clemens, John D, Deen, Jacqueline L, Shin, Sunheang, Schaetti, Christian, Hutubessy, Raymond, Aguado, Maria Teresa, Kieny, Marie Paule, Sack, David, Obaro, Stephen, Shaame, Attiye J, Ali, Said M, Saleh, Abdul A, von Seidlein, Lorenz, Jiddawi, Mohamed S

“…Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of the absence of…”
Get full text